Epstein-Barr virus detection using gastric biopsy specimens after rapid urease test for Helicobacter pylori

CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(04): E431-E432
DOI: 10.1055/a-0859-7233

Innovation forum

Authors

Hideo Yanai

¹Department of Clinical Research, National Hospital Organization Kanmon Medical Center, Yamaguchi, Japan
Hisashi Iizasa

²Department of Microbiology, Shimane University School of Medicine, Shimane, Japan
Daisuke Chihara

³Department of Gastroenterology & Hepatology, National Hospital Organization Kanmon Medical Center, Yamaguchi, Japan
Tomoyuki Murakami

⁴Department of Pathology, National Hospital Organization Kanmon Medical Center, Yamaguchi, Japan
Jun Nishikawa

⁵Department of Laboratory Science, Yamaguchi University Graduate School of Medicine, Ube, Japan
Hironori Yoshiyama

²Department of Microbiology, Shimane University School of Medicine, Shimane, Japan

References
1 The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513: 202-209
2 Murphy G, Pfeiffer R, Camargo MC. et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009; 137: 824-833
3 Yanai H, Murakami T, Yoshiyama H. et al. Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol 1999; 29: 39-43
4 Hirano A, Yanai H, Shimizu N. et al. Evaluation of Epstein-Barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Cancer 2003; 34: 87-94
5 Abadi ATB. Diagnosis of Helicobacter pylori using invasive and noninvasive approaches. J Pathog 2018;